104 related articles for article (PubMed ID: 26074876)
1. TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression.
Lin SJ; Yang DR; Li G; Chang C
Front Endocrinol (Lausanne); 2015; 6():78. PubMed ID: 26074876
[TBL] [Abstract][Full Text] [Related]
2. TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells.
Lin SJ; Yang DR; Wang N; Jiang M; Miyamoto H; Li G; Chang C
Oncoscience; 2015; 2(2):142-50. PubMed ID: 25859557
[TBL] [Abstract][Full Text] [Related]
3. Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases.
Liu S; Lin SJ; Li G; Kim E; Chen YT; Yang DR; Tan MH; Yong EL; Chang C
Endocr Relat Cancer; 2014 Jun; 21(3):R279-300. PubMed ID: 24623743
[TBL] [Abstract][Full Text] [Related]
4. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
[TBL] [Abstract][Full Text] [Related]
5. The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.
Lin SJ; Lin CY; Yang DR; Izumi K; Yan E; Niu X; Chang HC; Miyamoto H; Wang N; Li G; Chang C
Neoplasia; 2015 Apr; 17(4):339-47. PubMed ID: 25925376
[TBL] [Abstract][Full Text] [Related]
6. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.
Yang DR; Ding XF; Luo J; Shan YX; Wang R; Lin SJ; Li G; Huang CK; Zhu J; Chen Y; Lee SO; Chang C
J Biol Chem; 2013 Jun; 288(23):16476-16483. PubMed ID: 23609451
[TBL] [Abstract][Full Text] [Related]
7. Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.
Ding X; Yang DR; Xia L; Chen B; Yu S; Niu Y; Wang M; Li G; Chang C
Mol Cancer; 2015 Jan; 14(1):16. PubMed ID: 25623427
[TBL] [Abstract][Full Text] [Related]
8. TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals.
Bai J; Yeh S; Qiu X; Hu L; Zeng J; Cai Y; Zuo L; Li G; Yang G; Chang C
Oncogene; 2018 Nov; 37(44):5901-5912. PubMed ID: 29973687
[TBL] [Abstract][Full Text] [Related]
9. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity.
Chen D; Chou FJ; Chen Y; Tian H; Wang Y; You B; Niu Y; Huang CP; Yeh S; Xing N; Chang C
Cancer Lett; 2020 Dec; 495():100-111. PubMed ID: 32768524
[TBL] [Abstract][Full Text] [Related]
10. TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system.
Lin SJ; Lee SO; Lee YF; Miyamoto H; Yang DR; Li G; Chang C
Carcinogenesis; 2014 Jun; 35(6):1399-406. PubMed ID: 24583925
[TBL] [Abstract][Full Text] [Related]
11. TR2 and TR4 Orphan Nuclear Receptors: An Overview.
Lin SJ; Yang DR; Yang G; Lin CY; Chang HC; Li G; Chang C
Curr Top Dev Biol; 2017; 125():357-373. PubMed ID: 28527578
[TBL] [Abstract][Full Text] [Related]
12. Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer.
Yu S; Wang M; Ding X; Xia L; Chen B; Chen Y; Zhang Z; Niu Y; Li G; Chang C
Prostate; 2015 Oct; 75(14):1632-42. PubMed ID: 26178291
[TBL] [Abstract][Full Text] [Related]
13. Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype.
Zhang L; Zhang J; Ma Y; Chen J; Dong B; Zhao W; Wang X; Zheng Q; Fang F; Yang Y
Lung Cancer; 2015 Sep; 89(3):320-8. PubMed ID: 26144287
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
[TBL] [Abstract][Full Text] [Related]
15. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
[TBL] [Abstract][Full Text] [Related]
16. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
[TBL] [Abstract][Full Text] [Related]
17. Testicular Nuclear Receptor 4 Regulates Proliferation and Apoptosis of Bladder Cancer
Wang H; Luo W; Wang X; Xue D; Ren L; Xu L; Ge G; Xia L; Yu S; Wang M; Zhou Z; Li G; Wu H
Front Mol Biosci; 2021; 8():670409. PubMed ID: 34616769
[TBL] [Abstract][Full Text] [Related]
18. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B
Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614
[TBL] [Abstract][Full Text] [Related]
19. Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2α/androgen receptor signals.
Luo J; Lee SO; Cui Y; Yang R; Li L; Chang C
Oncotarget; 2015 Sep; 6(29):27555-65. PubMed ID: 26342197
[TBL] [Abstract][Full Text] [Related]
20. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145.
Guo W; Ren D; Chen X; Tu X; Huang S; Wang M; Song L; Zou X; Peng X
J Cell Biochem; 2013 Jul; 114(7):1606-15. PubMed ID: 23355420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]